RESUMEN
Chronic lymphocytic leukemia (CLL) patients with 17p deletion comprise a challenging subgroup associated with poor overall survival. These patients should be treated with alternative strategies. Reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) can achieve long-term remission in this ultra-high-risk CLL group. Herein, we described a CLL patient with 17p deletion who developed Richter syndrome with extranodal involvement of the liver soon after RIC allo-SCT despite apparent acute graft-versus-host disease. The majority of chronic lymphocytic leukemia (CLL) patients respond well to chemoimmunotherapy. Patients who show ultra-high-risk genetics, such as 17p deletions, comprise a challenging subgroup of patients with poor response to chemoimmunotherapy and median life expectancy <2-3 years at the time of first-line treatment. Current treatment approaches for patients with 17p deletion include agents acting independently from the DNA damage pathway, such as alemtuzumab and high-dose corticosteroids. RIC allo-SCT for consolidation can achieve long-term remission in this ultra-high-risk CLL group.(1,2) Richter syndrome (RS) represents the clinicopathologic transformation of CLL to an aggressive lymphoma, most commonly diffuse large B-cell lymphoma (DLBCL).(3) RS appearing after allo-SCT can be managed by tapering of immunosuppression, followed by dose-escalated donor lymphocyte infusion titrated to the degree of leukemia response and graft-versus-host disease (GVHD) encountered.(4) Herein, we describe a CLL patient with 17p deletion who developed RS with extranodal involvement of the liver soon after RIC allo-SCT despite apparent acute GVHD (aGVHD).
Asunto(s)
Deleción Cromosómica , Cromosomas Humanos Par 17 , Enfermedad Injerto contra Huésped , Leucemia Linfocítica Crónica de Células B/terapia , Trasplante de Células Madre , Femenino , Humanos , Leucemia Linfocítica Crónica de Células B/genética , Persona de Mediana Edad , SíndromeRESUMEN
Kikuchi-Fujimoto disease (KFD), a rare clinicopathological entity, is a benign and self-limiting disease. It was first described in 1972 by Kikuchi and Fujimoto in Japan independently. KFD is prevalent in Asia, although it may be seen in wide geographical areas, including Turkey. It mainly affects young women. Cervical lymphadenopathy is the most prominent sign and should be differentiated from lymphoproliferative, autoimmune, and infectious diseases. We report on a 30-year-old female patient who was referred to our medical oncology unit for chemotherapy and/or radiotherapy with diagnosis of Hodgkin's lymphoma. Ultimately her diagnosis was corrected as KFD after second opinion of the pathology specimens. We herein provide a brief review about KFD and the importance of second opinion of the pathology specimens.
Asunto(s)
Linfadenitis Necrotizante Histiocítica/diagnóstico , Enfermedad de Hodgkin/diagnóstico , Derivación y Consulta , Adulto , Diagnóstico Diferencial , Femenino , HumanosRESUMEN
Nasopharyngeal presentation of Hodgkin's disease (HD) is an uncommon event with relatively favorable prognosis. It is predominantly seen in males and most papers are case reports. Here, we report an unusual case in a female patient with stage IA(E)HD treated by radiotherapy (RT), and achieving complete disease remission, lasting 26(+) months.
Asunto(s)
Enfermedad de Hodgkin/diagnóstico , Neoplasias Nasofaríngeas/diagnóstico , Supervivencia sin Enfermedad , Femenino , Enfermedad de Hodgkin/radioterapia , Humanos , Persona de Mediana Edad , Neoplasias Nasofaríngeas/radioterapiaRESUMEN
BACKGROUND: Chemokines effect their proinflammatory and growth regulatory roles through interaction with serpentine receptors. One such receptor, CXCR2, binds multiple CXC chemokines, including interleukin 8, GRO-alpha, GRO-beta, GRO-gamma, and NAP-2. We have previously identified CXCR2 expression on myeloid cells, notably mature granulocytes, and projection neurons. OBJECTIVE: To determine the expression of CXCR2 by cells of the neuroendocrine system. DESIGN: Archival specimens from normal neuroendocrine tissues and their malignant counterparts were analyzed by immunohistochemistry with monoclonal antibodies specific for CXCR1 and CXCR2. RESULTS: Immunohistochemical analysis revealed high-level expression of CXCR2 by cells in the pituitary, adrenal medulla, pancreatic islets, thyroid C cells, scattered Kulchitsky cells in the bronchi, and counterpart neuroendocrine cells in the stomach, small bowel, colon, and appendix. Neuroendocrine neoplasms that demonstrated high-level CXCR2 expression included (1) primary carcinoids localized to the stomach, small bowel, colon, appendix, fallopian tube, ovary, and lung; (2) atypical carcinoids of the lung; (3) metastatic carcinoids; (4) pituitary adenomas; (5) pheochromocytomas; and (6) medullary carcinomas of the thyroid. Small cell lung carcinomas, large cell neuroendocrine carcinomas of the lung, small cell carcinoma of the cervix, Merkel cell carcinomas, neuroblastomas, and malignant melanomas lacked evidence of CXCR2 expression. CONCLUSIONS: The expression of CXCR2 by normal neuroendocrine cells and neoplastic counterparts that have retained phenotypic features of this differentiation program suggests that chemokines may play an important role in functions that are characteristic of this cell type. In addition, this raises the possibility that chemokines may modulate secretion of biologically active products of these cells and their neoplastic counterparts.
Asunto(s)
Neoplasias/inmunología , Neoplasias/patología , Tumores Neuroendocrinos/patología , Sistemas Neurosecretores/inmunología , Receptores de Quimiocina/análisis , Receptores de Interleucina/análisis , Anticuerpos Monoclonales , Antígenos CD/análisis , Femenino , Neoplasias Gastrointestinales/patología , Neoplasias de los Genitales Femeninos/patología , Humanos , Inmunohistoquímica/métodos , Interleucina-8/inmunología , Tumores Neuroendocrinos/inmunología , Sistemas Neurosecretores/citología , Sistemas Neurosecretores/patología , Especificidad de Órganos , Receptores de Interleucina-8A , Receptores de Interleucina-8B , Valores de ReferenciaRESUMEN
A vascularly isolated rabbit forelimb model simulating conditions of composite tissue allografting was used to determine the regional pharmacokinetic advantage achievable in extremity tissue components during i.a. tacrolimus (FK506) administration. FK506 was infused continuously via osmotic minipump into the right brachial artery of New Zealand rabbits at 0.05, 0.1, and 0.2 mg/kg/day. On day 6, FK506 concentrations were measured in aortic whole blood, heart, lung, liver, kidney, spleen, and fat, as well as in skin, muscle, bone, and bone marrow samples from both right and left forelimbs. The relative tissue concentrations of FK506 in descending order were [spleen approximately lung approximately kidney] > [heart approximately skin approximately muscle] > [fat approximately bone marrow] > [liver approximately bone approximately blood]. In marked contrast to previous results with i.a. cyclosporin A infusion, only a minimal regional advantage of local FK506 delivery (mean right/left concentration ratios 1.0-1.4) was obtained in all forearm tissues over the dose range studied. For each limb tissue, left-sided FK506 concentrations significantly correlated with systemic blood levels, and the left-sided tissue-to-whole-blood concentration ratio did not vary significantly with dose. We conclude that FK506 is pharmacokinetically inferior to cyclosporin A for continuous i.a. administration to the vascularly isolated rabbit forelimb, and hypothesize that this difference is the result of differences in the distribution of each drug within whole blood. Our findings suggest that, despite its demonstrated efficacy in experimental and clinical transplantation, FK506 would not be an appropriate immunosuppressant to deliver via the i.a. route for prevention of limb allograft rejection.
Asunto(s)
Arteria Braquial , Tacrolimus/administración & dosificación , Tacrolimus/farmacocinética , Animales , Médula Ósea/metabolismo , Huesos/metabolismo , Cateterismo Periférico , Relación Dosis-Respuesta a Droga , Miembro Anterior/irrigación sanguínea , Infusiones Intraarteriales , Masculino , Músculo Esquelético/metabolismo , Conejos , Piel/metabolismo , Tacrolimus/sangre , Distribución TisularRESUMEN
A fifty-three-year-old woman with pulmonary tuberculosis in association with lupus vulgaris is reported. Her condition had been misdiagnosed for several years; the need for early diagnosis of tuberculosis is emphasized again.
Asunto(s)
Lupus Vulgar/etiología , Tuberculosis Pulmonar/complicaciones , Femenino , Humanos , Lupus Vulgar/patología , Persona de Mediana Edad , Piel/patologíaRESUMEN
Fibroepithelial polyp of the renal pelvis is an extremely rare entity. We report a case of multiple fibroepithelial polyps of the renal pelvis and calyces and discuss this rare and confusing condition with its clinical, radiological and pathological findings.